Paddock Laboratories recalls
Paddock Laboratories appears in 3 official U.S. recall notices indexed by RecallRadar, most recently on 2018-04-04.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 3 |
|---|---|
| Published | 2012-10-17 to 2018-04-04 |
| By agency | FDA Drug (3) |
| By classification | Class II (3) |
| By status | terminated (3) |
| Distribution named in notices | US |
Recalls
- Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapol…
FDA Drug · Class II · 2018-04-04 · Paddock Laboratories
Reason: Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product. - Perrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75mg/5mL, 100 ml, NDC 0574-0129-01
FDA Drug · Class II · 2014-03-26 · Paddock Laboratories
Reason: Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml. - Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01
FDA Drug · Class II · 2012-10-17 · Paddock Laboratories
Reason: Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 mont…